|
Genamics JournalSeek
Endocrine, Metabolic & Immune Disorders - Drug Targets
ISSN (printed): 1871-5303. ISSN (electronic): 2212-3873.
This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders (1568-0088).
- Further information
-
- Category Links
|
